Managing immune-mediated hemolytic anemia in dogs

Veterinary Medicine

Volumn 94, Issue 6, 1999, Pages 532-546

  Lifton, Stephanie J ^a  

^a ANTECH DIAGNOSTICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0005899038     PISSN: 87507943     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (63)

1. Klag, A.R. et al.: Idiopathic immune-mediated hemolytic anemia in dogs: 42 cases (1986-1990). JAVMA 202(5):783-788; 1993.
2. Bucheler, J.; Cotter, S.M.: Canine immune-mediated hemolytic anemia. Kirk's Current Veterinary Therapy XII Small Animal Practice (J.D. Bonagura, ed.). W.B. Saunders, Philadelphia, Pa., 1995; pp 152-157.
3. Brunner, C.J.: Autoimmunity. Kirk's Current Veterinary Therapy XII Small Animal Practice (J.D. Bonagura, ed.). W.B. Saunders, Philadelphia, Pa., 1995; pp 554-560.
4. Gorman, N.T.: Immunology. Textbook of Veterinary Internal Medicine, 4th Ed. (S.J. Eltinger; E.C. Feldman, eds.). W.B. Saunders, Philadelphia, Pa., 1995; pp 1978-2002.
5. Halliwell, R.E.W.; Gorman, N.T.: Autoimmune blood disease. Veterinary Clinical Immunology (R.E.W. Halliwell; N.T. Gorman, eds.). W.B. Saunders, Philadelphia, Pa., 1989; pp 308-335.
6. Patterson, R.; Anderson, J.: Allergic reactions to drugs and biologic agents. JAMA 248:2637-2645; 1982.
7. Packman, C.H.; Leddy, J.P.: Acquired hemolytic anemia due to warm-reacting autoantibodies. Hematology, 4th Ed. (J.W. Williams et al., eds.). McGraw-Hill, New York, N.Y., 1990; pp 666-675.
8. Atkinson, J.P.: Factors that alter erythrocyte clearance patterns. Ann. Intern. Med. 87:213-217; 1977.
9. Cotter, S.M.: Autoimmune hemolytic anemia in dogs. Compend. Com. Ed. 14(1):53-59; 1992.
10. Honeckman, A.L. et al.: Diagnosis of canine immune-mediated hematologic disease. Compend. Cont. Ed. 18(2):113-125; 1996.
11. Thompson, J.P.: Immunologic diseases. Textbook of Veterinary Internal Medicine, 4th Ed. (S.J. Ettinger; E.C. Feldman, eds.). W.B. Saunders, Philadelphia, Pa., 1995; pp 2002-2029.
12. Slappendel, R.J.: The diagnostic significance of the direct antiglobulin test (DAT) in anemic dogs. Vet. Immunol. Immunopathol. 1:49-59; 1979.
13. Allyn, M.E.; Troy, G.C.: Immune mediated hemolytic anemia - A retrospective study: Focus on treatment and mortality (1988-1996) (abst.). Proc. ACVIM, ACVIM, Lakewood, Colo., 1997; p 678.
14. Kellerman, D.L.; Bruyette, D.S.: Intravenous human immunoglobulin for the treatment of immune-mediated hemolytic anemia in 13 dogs. J. Vet. Intern. Med. 11(6):327-332; 1997.
15. Carr, A.P.; Panciera, D.L.: Immune-mediated hemolytic anemia in dogs: A retrospective study with emphasis on hemostatic parameters (abst.). Proc. ACVIM, ACVIM, Lakewood, Colo., 1996; p 754.
16. Scott-Moncrieff, J.C.R. et al.: Intravenous administration of human immune globulin in dogs with immune-mediated hemolytic anemia. JAVMA 210(11):1623-1627; 1997.
17. Klag, A.R.: Hemolytic anemia in dogs. Compend. Cont. Ed. 14(8):1090-1098; 1992.
18. Weiser, M.G.: Erythrocyte responses and disorders. Textbook of Veterinary Internal Medicine, 4th Ed. (S.J. Ettinger; E.C. Feldman, eds.). W.B. Saunders, Philadelphia, Pa., 1995; pp 1864-1891.
19. Duval, D.; Giger, U.: Vaccine-associated immune-mediated hemolytic anemia in the dog. J. Vet. Intern. Med 10(5):290-295; 1996.
20. Tvedten, H.: Erythrocyte disorders. Small Animal Clinical Diagnosis by Laboratory Methods (M.D. Willard et al., eds.). W.B. Saunders, Philadelphia, Pa., 1989; pp 35-56.
21. Hauke, G. et al.: Reticulocytopenia in severe autoimmune hemolytic anemia (AIHA) of the warm antibody type. Blut 46:321-327; 1983.
22. Giger, U.: Erythropoietin and its clinical use. Compend. Cont. Ed. 14(1):25-34; 1992.
23. Stewart, A.F.; Feldman B.F.: Immune-mediated hemolytic anemia. Part II. Clinical entity, diagnosis, and treatment theory. Compend. Cont. Ed. 15(11):1479-1491; 1993.
24. Green, R.A.; Thomas, J.S. Hemostatic disorders: Coagulopathies and thrombosis. Textbook of Veterinary Internal Medicine, 4th Ed. (S.J. Ettinger; E.C. Feldman, eds.). W.B. Saunders, Philadelphia, Pa., 1995; pp 1946-1963.
25. Klein, M.K. et al.: Pulmonary thromboembolism associated with immune-mediated hemolytic anemia in dogs: Ten cases (1982-1987). JAVMA 195(2):246-250; 1989.
26. Schafer, A.I.: The hypercoagulable states. Ann. Intern. Med. 102:814-828; 1985.
27. Stern, D. et al.: An endothelial cell-dependent pathway of coagulation. Proc. Natl. Acad. Sci. United States Am. 82:2523-2527; 1985.
28. Tannenbaum, S.H. et al.: Antibody and immune complexes induce tissue factor production by human endothelial cells. J. Immunol. 137:1532-1537; 1986.
29. Johnson, L.R.; Hamlin, R.L.: Recognition and treatment of pulmonary hypertension. Kirk's Current Veterinary Therapy XII Small Animal Practice (J.D. Bonagura, ed.). W.B. Saunders, Philadelphia, Pa., 1995; pp 887-894.
30. Feldman, E.C.: Hyperadrenocorticism. Textbook of Veterinary Internal Medicine, 4th Ed. (S.J. Ettinger; E.C. Feldman, eds.). W.B. Saunders, Philadelphia, Pa., 1995; pp 1538-1578.
31. Patrassi, G.M. et al.: The fibrinolytic potential in patients with Cushing's disease: A clue to their hypercoagulable state. Blood Coagulation Fibrinolysis 3:789-793; 1992.
32. LaRue, M.J.; Murtaugh, R.J.: Pulmonary thromboembolism in dogs: 47 cases. JAVMA 197(10):1368-1372; 1990.
33. Rosenow, E.C. et al.: Pulmonary embolism. Mayo Clin. Proc. 56:161-178; 1981.
34. Fluckiger, M.A.; Gomez, J.A.: Radiographic findings in dogs with spontaneous pulmonary thrombosis or embolism. Vet. Radiol. 25:124-131; 1984.
35. Noone, K.E.: Pleural effusions and diseases of the pleura. Vet. Clin. North Am. (Small Anim. Pract.) 15:1069-1084; 1985.
36. Aldrich, J.; Haskins, S.C.: Monitoring the critically ill patient. Kirk's Current Veterinary Therapy XII Small Animal Practice (J.D. Bonagura, ed.). W.B. Saunders, Philadelphia, Pa., 1995; pp 98-105.
37. Kellerman, D.L. et al.: Determination of and monitoring of a therapeutic heparin dosage in the dog (abst.). Proc. ACVIM, ACVIM, Lakewood, Colo., 1995; p 1002.
38. Dennis, J.S.: Clinical features of canine pulmonary thromboembolism. Compend. Cont. Ed. 15(12):1595-1603; 1993.
39. Giger, U.; Rentko, V.T.: Alternatives to blood transfusions. Proc. ACVIM, ACVIM, Lakewood, Colo., 1998; pp 430-431.
40. Pedersen, N.C.: Therapy of immune-mediated diseases. Current Veterinary Therapy VIII Small Animal Practice (R.W. Kirk, ed.). W.B. Saunders, Philadelphia, Pa., 1983; pp 443-447.
41. Rosenthal, R.C.: Chemotherapy. Textbook of Veterinary Internal Medicine, 4th Ed. (S.J. Ettinger; E.C. Feldman, eds.). W.B. Saunders, Philadelphia, Pa., 1995; pp 473-484.
42. Mason, N.J. et al.: Evaluation of combined cyclophosphamide and prednisone versus prednisone alone in the treatment of canine immune-mediated hemolytic anemia (abst.). Proc. ACVIM, ACVIM, Lakewood, Colo., 1997; p 677.
43. Beale, K.M.: Azathioprine for treatment of immune-mediated diseases of dogs and cats. JAVMA 192(9):1316-1318; 1988.
44. Pignon, J.M. et al.: Danazol in autoimmune haemolytic anaemia. Br. J. Haematol. 83(2):343-345; 1993.
45. Miller, E.: Danazol therapy for the treatment of immune-mediated hemolytic anemia in dogs (abst.). Proc. ACVIM, ACVIM, Lakewood, Colo., 1997; p 677.
46. Vaden, S.L.: Cyclosporine. Kirk's Current Veterinary Therapy XII Small Animal Practice (J.D. Bonagura, ed.). W.B. Saunders, Philadelphia, Pa., 1995; pp 73-77.
47. Emilia, G. et al.: Long-term salvage treatment by cyclosporine in refractory autoimmune haematological disorders. Br. J. Haematol. 93(2):341-344; 1996.
48. Flores, G. et al.: Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: Results in 73 patients. Am. J. Hematol. 44:237-242; 1993.
49. Lusher, J.M.; Warrier, I.: Use of intravenous gamma globulin in children and adolescents with idiopathic thrombocytopenia purpura and other immune thrombocytopenias. Am. J. Med. 83(4A):10-16; 1987.
50. Hilgartner, M.W.; Bussel, J.: Use of intravenous gamma globulins for the treatment of autoimmune neutropenia of childhood and autoimmune hemolytic anemia. Am. J. Med. 83(4A):25-29; 1987.
51. McGuire, W.A. et al.: Treatment of antibody mediated pure red cell aplasia with high dose intravenous gamma globulin. N. Engl. J. Med. 317:1004-1008; 1987.
52. Bussel, J.B.; Pham, L.C.: Intravenous treatment with gammaglobulin in adults with immune thrombocytopenic purpura: Review of the literature. Vox Sang. 52:206-211; 1987.
53. Blanchette, V. et al.: Randomized trial of intravenous immunoglobulin G, intravenous anti-D and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 344:703-707; 1994.
54. Ballow, M.: Mechanisms of action of intravenous immunoglobulin therapy and potential use in autoimmune connective tissue diseases. Cancer 68:1430-1436; 1991.
55. Debre, M. et al.: Infusion of Fc fragments for treatment of children with acute immune thrombocytopenia purpura. Lancet 342:945-949; 1993.
56. Basta, M. et al.: Mechanism of therapeutic effect of high dose intravenous immunoglobulin: Attenuation of acute, complement-dependent immune damage in a guinea pig model. J. Clin. Invest. 84:1974-1981; 1989.
57. Kondo, K. et al.: Suppression of immunoglobulin production of lymphocytes by intravenous immunoglobulin. J. Clin. Immunol. 11(3):152-158; 1991.
58. Van Schaik, N. et al.: Polyvalent immunoglobulin for intravenous use interferes with cell proliferation in vitro. J. Clin. Immunol. 12(5):325-334; 1992.
59. Andersson, U.G. et al.: Down-regulation of cytokine production and interleukin-2 receptor expression by pooled human IgG. Immunology 79:211-216; 1993.
60. Amran, D. et al.: Suppression of cytokine-dependent human T-cell proliferation by intravenous immunoglobulin. Clin. Immunol. Immunopathol. 73:180-186; 1994.
61. Scott-Moncrieff, J.C.R. et al.: Treatment of nonregenerative anemia with human gammaglobulin in dogs. JAVMA 206(12):1895-1900; 1995.
62. Dameshek, A.C.; Ellis, L.D.: Hematologic indications for splenectomy. Surg. Clin. North Am. 55:253-275; 1975.
63. Bartges, J.W.: Therapeutic plasmapheresis. Semin. Vet. Med. Surg. 12(3):170-177; 1997.